HEALTHEQUITY, INC.HQY
HEALTHEQUITY, INC. Commitments Disclosure
Commitments and contingencies
Commitments
The following table summarizes the payments due by fiscal year for the Company's outstanding contractual obligations as of January 31, 2026:
| Payments due by fiscal year | |||||||||||||||||||||||||||||||||||||||||
| (in thousands) | 2027 | 2028 | 2029 | 2030 | 2031 | Thereafter | Total | ||||||||||||||||||||||||||||||||||
4.50% Senior Notes due 2029 (1) | $ | — | $ | — | $ | — | $ | 600,000 | $ | — | $ | — | $ | 600,000 | |||||||||||||||||||||||||||
| Revolving Credit Facility (1) | — | — | — | 361,875 | — | — | 361,875 | ||||||||||||||||||||||||||||||||||
| Interest on long-term debt obligations (2) | 45,425 | 45,425 | 45,476 | 26,935 | — | — | 163,261 | ||||||||||||||||||||||||||||||||||
| Operating lease obligations (3) | 10,148 | 10,323 | 10,553 | 10,789 | 7,140 | — | 48,953 | ||||||||||||||||||||||||||||||||||
| Other contractual obligations (4) | 66,124 | 54,693 | 13,050 | 4,146 | 851 | — | 138,864 | ||||||||||||||||||||||||||||||||||
| Total | $ | 121,697 | $ | 110,441 | $ | 69,079 | $ | 1,003,745 | $ | 7,991 | $ | — | $ | 1,312,953 | |||||||||||||||||||||||||||
(1)As of January 31, 2026, the outstanding combined principal of $961.9 million is presented net of debt issuance costs on the consolidated balance sheets. The debt issuance costs are not included in the table above.
(2)Estimated interest payments assume the stated interest rates applicable to the Notes and Revolving Credit Facility as of January 31, 2026, which were 4.50% and 5.02% per annum, respectively.
(3)The Company leases office space and data storage facilities and has other non-cancelable operating leases expiring at various dates through 2030. These amounts exclude contractual sublease income of $22.5 million, which is expected to be received through December 2030.
(4)Other contractual obligations consist of services agreements, purchase obligations, and other contractual commitments.
Contingencies
In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future but have not yet been made. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.
Legal matters
As a result of a cybersecurity incident in 2024 in which a business partner's user account containing personally identifiable information was breached, the Company is subject to multiple legal actions, including a consolidated putative class action lawsuit in federal court in the District of Utah. The plaintiffs in these legal actions allege that the Company failed to implement reasonable data security practices, which resulted in a breach and disclosure of plaintiffs' and others' personally identifiable information and protected health information. The plaintiffs are seeking,
among other damages, unspecified monetary damages, equitable relief, costs and attorneys' fees arising out of the incident. With respect to the consolidated putative class action lawsuit, on August 22, 2024, the court issued an order granting a motion to consolidate the class action lawsuits, on October 15, 2024, a consolidated class action amended complaint was filed, on December 13, 2024, the Company filed a motion to dismiss the class action and a motion to compel arbitration, and on May 5, 2025, the court dismissed without prejudice the Company's motion to compel arbitration and the motion to dismiss, with the court noting that the Company could refile both motions after the conclusion of discovery. The Company intends to vigorously defend these legal actions. In addition, the Company is subject to several regulatory inquiries related to the cybersecurity incident. The amount of the potential loss associated with these lawsuits and any potential regulatory action cannot be reasonably estimated based on currently available information.
The Company and its subsidiaries are involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. It is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, or the impact that such litigation, proceedings and claims will have on the Company’s financial position, results of operations, and cash flows.
As required under GAAP, the Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No loss accrual relating to these matters was recorded because, based on currently available information, the Company does not believe that any contingent liabilities relating to these matters are probable or that the amount of any resulting loss is estimable. However, litigation is subject to inherent uncertainties and the Company’s view of these matters may change. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position, results of operations and cash flows for the period in which the unfavorable outcome occurs, and potentially in future periods.
Free Sentinel
Track for freeWant the next HEALTHEQUITY, INC. commitments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment HEALTHEQUITY, INC.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Mar 17, 2026 | Showing above |
| 2025 | Mar 18, 2025 | |
| 2024 | Mar 22, 2024 | |
| 2023 | Mar 30, 2023 | |
| 2022 | Mar 31, 2022 | |
| 2021 | Mar 31, 2021 | |
| 2020 | Mar 31, 2020 | |
| 2019 | Mar 28, 2019 | |
| 2018 | Mar 28, 2018 | |
| 2017 | Mar 30, 2017 | |
| 2016 | Mar 31, 2016 | |
About Commitments Disclosures
Commitments and contingencies disclosures catalog a company's off-balance-sheet obligations and legal exposures — purchase commitments, guarantee arrangements, pending litigation, and regulatory proceedings. These items represent potential future cash outflows that may not appear as liabilities on the balance sheet until they become probable and estimable.
Key signals: litigation reserves and disclosed loss ranges quantify management's estimate of legal exposure, but unquantified "reasonably possible" losses often represent the larger risk. Watch for changes in language around pending cases — shifts from "remote" to "reasonably possible" or increases in estimated loss ranges signal deteriorating outcomes. Unconditional purchase obligations and take-or-pay contracts create fixed cost structures that reduce operational flexibility. Guarantee arrangements for subsidiaries or joint ventures can create cascading obligations. Compare the total commitment schedule against projected free cash flow to assess whether the company can meet its obligations without additional financing.